Acasti Pharma Stock Market Value
| ACST Stock | USD 2.76 0.13 4.50% |
| Symbol | Acasti |
Acasti Pharma Price To Book Ratio
Is Acasti Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Acasti Pharma. If investors know Acasti will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Acasti Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.68) | Revenue Per Share 0.005 | Return On Assets (0.08) | Return On Equity (0.48) |
The market value of Acasti Pharma is measured differently than its book value, which is the value of Acasti that is recorded on the company's balance sheet. Investors also form their own opinion of Acasti Pharma's value that differs from its market value or its book value, called intrinsic value, which is Acasti Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Acasti Pharma's market value can be influenced by many factors that don't directly affect Acasti Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Acasti Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Acasti Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Acasti Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Acasti Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Acasti Pharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Acasti Pharma.
| 04/10/2024 |
| 05/10/2024 |
If you would invest 0.00 in Acasti Pharma on April 10, 2024 and sell it all today you would earn a total of 0.00 from holding Acasti Pharma or generate 0.0% return on investment in Acasti Pharma over 30 days. Acasti Pharma is related to or competes with Tonix Pharmaceuticals, Jaguar Animal, Ibio, Akari Therapeutics, Aditxt, ABVC Biopharma, and Pulmatrix. Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical prod... More
Acasti Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Acasti Pharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Acasti Pharma upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.35 | |||
| Information Ratio | 0.0902 | |||
| Maximum Drawdown | 23.5 | |||
| Value At Risk | (5.76) | |||
| Potential Upside | 7.4 |
Acasti Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Acasti Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Acasti Pharma's standard deviation. In reality, there are many statistical measures that can use Acasti Pharma historical prices to predict the future Acasti Pharma's volatility.| Risk Adjusted Performance | 0.0782 | |||
| Jensen Alpha | 0.4513 | |||
| Total Risk Alpha | (0.03) | |||
| Sortino Ratio | 0.0972 | |||
| Treynor Ratio | (0.56) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Acasti Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Acasti Pharma Backtested Returns
Acasti Pharma appears to be risky, given 3 months investment horizon. Acasti Pharma secures Sharpe Ratio (or Efficiency) of 0.0628, which signifies that the company had a 0.0628% return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for Acasti Pharma, which you can use to evaluate the volatility of the firm. Please makes use of Acasti Pharma's risk adjusted performance of 0.0782, and Mean Deviation of 2.18 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Acasti Pharma holds a performance score of 4. The firm shows a Beta (market volatility) of -0.71, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Acasti Pharma are expected to decrease at a much lower rate. During the bear market, Acasti Pharma is likely to outperform the market. Please check Acasti Pharma's coefficient of variation, semi variance, period momentum indicator, as well as the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether Acasti Pharma's price patterns will revert.
Auto-correlation | -0.07 |
Very weak reverse predictability
Acasti Pharma has very weak reverse predictability. Overlapping area represents the amount of predictability between Acasti Pharma time series from 10th of April 2024 to 25th of April 2024 and 25th of April 2024 to 10th of May 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Acasti Pharma price movement. The serial correlation of -0.07 indicates that barely 7.0% of current Acasti Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.07 | |
| Spearman Rank Test | 0.2 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Acasti Pharma lagged returns against current returns
Autocorrelation, which is Acasti Pharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Acasti Pharma's stock expected returns. We can calculate the autocorrelation of Acasti Pharma returns to help us make a trade decision. For example, suppose you find that Acasti Pharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Acasti Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Acasti Pharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Acasti Pharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Acasti Pharma stock over time.
Current vs Lagged Prices |
| Timeline |
Acasti Pharma Lagged Returns
When evaluating Acasti Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Acasti Pharma stock have on its future price. Acasti Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Acasti Pharma autocorrelation shows the relationship between Acasti Pharma stock current value and its past values and can show if there is a momentum factor associated with investing in Acasti Pharma.
Regressed Prices |
| Timeline |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Acasti Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Acasti Pharma's short interest history, or implied volatility extrapolated from Acasti Pharma options trading.
Pair Trading with Acasti Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Acasti Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acasti Pharma will appreciate offsetting losses from the drop in the long position's value.Moving together with Acasti Stock
| 0.68 | ELEV | Elevation Oncology Financial Report 20th of May 2024 | PairCorr |
Moving against Acasti Stock
| 0.55 | EWTX | Edgewise Therapeutics | PairCorr |
The ability to find closely correlated positions to Acasti Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Acasti Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Acasti Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Acasti Pharma to buy it.
The correlation of Acasti Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Acasti Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Acasti Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Acasti Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Acasti Pharma Correlation, Acasti Pharma Volatility and Acasti Pharma Alpha and Beta module to complement your research on Acasti Pharma. For more information on how to buy Acasti Stock please use our How to Invest in Acasti Pharma guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for Acasti Stock analysis
When running Acasti Pharma's price analysis, check to measure Acasti Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acasti Pharma is operating at the current time. Most of Acasti Pharma's value examination focuses on studying past and present price action to predict the probability of Acasti Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acasti Pharma's price. Additionally, you may evaluate how the addition of Acasti Pharma to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Stocks Directory Find actively traded stocks across global markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |
Acasti Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.